04 November 2017 : Clinical Research
Clinical and Radiological Analysis of Bryan Cervical Artificial Disc Replacement for “Skip” Multi-Segment Cervical Spondylosis: Long-Term Follow-Up Results
Zikun Shang12ABCEF, Yingze Zhang32ABF, Di Zhang32BCEF, Wenyuan Ding32BCD, Yong Shen12ADE*DOI: 10.12659/MSM.904863
Med Sci Monit 2017; 23:5254-5263
Abstract
BACKGROUND: The aim of this study was to retrospectively analyze the clinical and radiological efficacy of Bryan cervical artificial disc replacement (ADR) for “skip” multi-segment cervical spondylosis (SCS).
MATERIAL AND METHODS: We enrolled 49 patients with SCS treated with either Bryan cervical ADR (18 cases) or ACDF (31 cases). Each case was evaluated preoperatively and at more than 48 months postoperatively in follow-up using the JOA, NDI, and VAS. Cervical sagittal curvature, total cervical ROM, and degree of middle segments of motion were also evaluated. MRI was used to assess adjacent segment degeneration(ASD), spinal cord compression, and signal changes.
RESULTS: The JOA, NDI, and VAS scores in the 2 groups improved significantly postoperatively. At the last follow-up, the results of Group Bryan were better than those of Group ACDF with respect to the incidence of axial symptoms (11.1% and 45.2%, respectively), VAS, ROM, and the degree of middle segments of motion. The ROM in Group Bryan was 38.2±4.6° and in Group ACDF was 25.3±4.6°. The middle segments of motion were 8.4±2.0° in Group Bryan and 12.2±2.2° in Group ACDF. There were no patients with ASD in Group Bryan. In Group ACDF, 1 case with an internal fixation device developed dislocation, and 2 cases developed degeneration, but there was no need for reoperation.
CONCLUSIONS: ADR for SCS can effectively improve neurological function and retain the overall activity of the cervical, thereby reducing ASD and the incidence of postoperative axial symptoms.
Keywords: Cervical Vertebrae, intervertebral disc degeneration, Neck Pain, Total Disc Replacement
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952